These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24050242)

  • 41. Application and interpretation of current autophagy inhibitors and activators.
    Yang YP; Hu LF; Zheng HF; Mao CJ; Hu WD; Xiong KP; Wang F; Liu CF
    Acta Pharmacol Sin; 2013 May; 34(5):625-35. PubMed ID: 23524572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases.
    Suresh SN; Chakravorty A; Giridharan M; Garimella L; Manjithaya R
    J Mol Biol; 2020 Apr; 432(8):2822-2842. PubMed ID: 32105729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases.
    Li J; Gao Y; Ren X; Li Y; Wu L; Yang X; Wang J; Shang H; Xiong X; Xing Y
    Curr Pharm Des; 2017; 23(7):1060-1069. PubMed ID: 27774897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanomaterial-modulated autophagy: underlying mechanisms and functional consequences.
    Zheng W; Wei M; Li S; Le W
    Nanomedicine (Lond); 2016 Jun; 11(11):1417-30. PubMed ID: 27193191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted protein degraders march towards the clinic for neurodegenerative diseases.
    Kumar D; Hassan MI
    Ageing Res Rev; 2022 Jun; 78():101616. PubMed ID: 35378298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders.
    Tomoshige S; Ishikawa M
    Angew Chem Int Ed Engl; 2021 Feb; 60(7):3346-3354. PubMed ID: 32410219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.
    Galluzzi L; Bravo-San Pedro JM; Levine B; Green DR; Kroemer G
    Nat Rev Drug Discov; 2017 Jul; 16(7):487-511. PubMed ID: 28529316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inducing autophagy harmlessly.
    Yuan J
    Autophagy; 2008 Feb; 4(2):249-50. PubMed ID: 18094626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbial Genetic Screens for Monitoring Protein Misfolding Associated with Neurodegeneration: Tools for Identifying Disease-Relevant Genes and for Screening Synthetic and Natural Compound Libraries for the Discovery of Potential Therapeutics.
    Kostelidou K; Matis I; Skretas G
    Curr Pharm Des; 2018; 24(19):2055-2075. PubMed ID: 29766788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small molecule probes for targeting autophagy.
    Whitmarsh-Everiss T; Laraia L
    Nat Chem Biol; 2021 Jun; 17(6):653-664. PubMed ID: 34035513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical Biology Strategies to Study Autophagy.
    Mishra P; Ammanathan V; Manjithaya R
    Front Cell Dev Biol; 2018; 6():160. PubMed ID: 30538986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Potential of genistein-induced autophagy in the treatment of neurodegenerative diseases].
    Pierzynowska K; Cyske Z; Gaffke L; Rintz E; Mantej J; Podlacha M; Wiśniewska K; Ĺťabińska M; Sochocka M; Lorenc P; Bielańska P; Giecewicz I; Węgrzyn G
    Postepy Biochem; 2021 Jun; 67(2):117-129. PubMed ID: 34378891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trehalose-Bearing Carriers to Target Impaired Autophagy and Protein Aggregation Diseases.
    Maruf A; Milewska M; Varga M; Wandzik I
    J Med Chem; 2023 Dec; 66(23):15613-15628. PubMed ID: 38031413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autophagy in neuroinflammatory diseases.
    Muller S; Brun S; René F; de Sèze J; Loeffler JP; Jeltsch-David H
    Autoimmun Rev; 2017 Aug; 16(8):856-874. PubMed ID: 28572049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease.
    Hernandez SJ; Fote G; Reyes-Ortiz AM; Steffan JS; Thompson LM
    Matrix Biol Plus; 2021 Dec; 12():100089. PubMed ID: 34786551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preface Drug discovery in neurodegenerative disorders: a defeat for pharmacology?
    Caraci F; Kraneveld A; Krzan M; Luca MD
    Eur J Pharmacol; 2017 Dec; 817():1. PubMed ID: 29162230
    [No Abstract]   [Full Text] [Related]  

  • 57. [Identification of a candidate therapeutic autophagy-inducing peptide].
    Shoji-Kawata S
    Seikagaku; 2015 Aug; 87(4):481-4. PubMed ID: 26571624
    [No Abstract]   [Full Text] [Related]  

  • 58. HAMdb: a database of human autophagy modulators with specific pathway and disease information.
    Wang NN; Dong J; Zhang L; Ouyang D; Cheng Y; Chen AF; Lu AP; Cao DS
    J Cheminform; 2018 Jul; 10(1):34. PubMed ID: 30066211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present).
    Kleczkowska P; Kowalczyk A; Lesniak A; Bujalska-Zadrozny M
    Curr Top Med Chem; 2017; 17(8):875-894. PubMed ID: 27538458
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.